NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,873 | +2.1% | 2,374 | +1.1% | 0.03% | +3.7% |
| Q2 2023 | $236,895 | +10.0% | 2,348 | +0.3% | 0.03% | -3.6% |
| Q1 2023 | $215,425 | +3.2% | 2,341 | +1.8% | 0.03% | -3.4% |
| Q4 2022 | $208,709 | -0.1% | 2,300 | -7.0% | 0.03% | 0.0% |
| Q2 2022 | $209,000 | -2.8% | 2,473 | +1.1% | 0.03% | +7.4% |
| Q1 2022 | $215,000 | 0.0% | 2,447 | -0.4% | 0.03% | +3.8% |
| Q4 2021 | $215,000 | -2.7% | 2,457 | -9.2% | 0.03% | -13.3% |
| Q3 2021 | $221,000 | +2.8% | 2,705 | +14.6% | 0.03% | -26.8% |
| Q2 2021 | $215,000 | +2.4% | 2,361 | -4.2% | 0.04% | -4.7% |
| Q1 2021 | $210,000 | -5.8% | 2,465 | +5.1% | 0.04% | -17.3% |
| Q4 2020 | $223,000 | +9.9% | 2,346 | 0.0% | 0.05% | -5.5% |
| Q3 2020 | $203,000 | -3.8% | 2,346 | -3.1% | 0.06% | -12.7% |
| Q2 2020 | $211,000 | -6.2% | 2,422 | -7.6% | 0.06% | -12.5% |
| Q4 2018 | $225,000 | – | 2,621 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |